Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-12-03 13:03:44 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1158/1078-0432.CCR-19-2299
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Kristine A. Frerichs; Marloes E.C. Broekmans; Jhon A. Marin Soto; Berris van Kessel; Martijn W. Heymans; Lisa C. Holthof; Christie P.M. Verkleij; Rengasamy Boominathan; Bhavesh Vaidya; Jocelyn Sendecki; Amy Axel; Francois Gaudet; Kodandaram Pillarisetti; Sonja Zweegman; Homer C. Adams; Tuna Mutis; Niels W.C.J. van de Donk
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/26/9/2203/2066483/2203.pdf

